JP2004503217A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004503217A5 JP2004503217A5 JP2002500917A JP2002500917A JP2004503217A5 JP 2004503217 A5 JP2004503217 A5 JP 2004503217A5 JP 2002500917 A JP2002500917 A JP 2002500917A JP 2002500917 A JP2002500917 A JP 2002500917A JP 2004503217 A5 JP2004503217 A5 JP 2004503217A5
- Authority
- JP
- Japan
- Prior art keywords
- ligand
- cell
- host cell
- presenting
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003446 ligand Substances 0.000 claims 9
- 210000004027 cell Anatomy 0.000 claims 8
- 230000002163 immunogen Effects 0.000 claims 6
- 210000000612 antigen-presenting cell Anatomy 0.000 claims 4
- 102000040430 polynucleotide Human genes 0.000 claims 4
- 108091033319 polynucleotide Proteins 0.000 claims 4
- 239000002157 polynucleotide Substances 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000012642 immune effector Substances 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 229940121354 immunomodulator Drugs 0.000 claims 2
- 210000004443 dendritic cell Anatomy 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20938800P | 2000-05-31 | 2000-05-31 | |
| US25700700P | 2000-12-20 | 2000-12-20 | |
| PCT/US2001/017454 WO2001092306A2 (en) | 2000-05-31 | 2001-05-30 | Therapeutic compounds for ovarian cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004503217A JP2004503217A (ja) | 2004-02-05 |
| JP2004503217A5 true JP2004503217A5 (enExample) | 2005-02-17 |
Family
ID=26904120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002500917A Pending JP2004503217A (ja) | 2000-05-31 | 2001-05-30 | 卵巣癌のための治療化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6737062B2 (enExample) |
| EP (1) | EP1284997B1 (enExample) |
| JP (1) | JP2004503217A (enExample) |
| AT (1) | ATE292640T1 (enExample) |
| AU (1) | AU2001265188A1 (enExample) |
| CA (1) | CA2410895A1 (enExample) |
| DE (1) | DE60109922D1 (enExample) |
| WO (1) | WO2001092306A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004514412A (ja) * | 2000-05-31 | 2004-05-20 | ジェンザイム・コーポレーション | 卵巣癌のための治療化合物 |
| DE60109922D1 (de) | 2000-05-31 | 2005-05-12 | Genzyme Corp | Therapeutische verbindungen gegen eierstockkrebs |
| US20020164346A1 (en) * | 2001-02-14 | 2002-11-07 | Nicolette Charles A. | Altered peptide ligands |
| AU2002256054A1 (en) * | 2001-04-04 | 2002-10-21 | Genzyme Corporation | Novel eps8 compounds for therapy and diagnosis and methods for using same |
| AU2002232563A1 (en) * | 2001-12-05 | 2003-06-23 | Genzyme Corporation | Compounds for therapy and diagnosis and methods for using same |
| US20050175588A1 (en) * | 2002-02-11 | 2005-08-11 | Mosca Joseph D. | Production of a protein delivery system for in vivo therapeutic treatment |
| JP2005191530A (ja) * | 2003-12-03 | 2005-07-14 | Sumitomo Electric Ind Ltd | 発光装置 |
| UY30915A1 (es) * | 2007-02-16 | 2008-09-02 | Smithkline Beecham Corp | Método de tratamiento de canceres |
| US20110160130A1 (en) * | 2007-02-16 | 2011-06-30 | Connie Erickson-Miller | Cancer treatment method |
| US20110129550A1 (en) | 2007-02-16 | 2011-06-02 | Connie Erickson-Miller | Cancer treatment method |
| CN101888841B (zh) * | 2007-10-09 | 2012-09-26 | 宾夕法尼亚大学理事会 | 血小板生成素受体激动剂(TpoRA)杀死急性人骨髓样白血病细胞 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4754065A (en) | 1984-12-18 | 1988-06-28 | Cetus Corporation | Precursor to nucleic acid probe |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5837249A (en) | 1985-04-19 | 1998-11-17 | The Wistar Institute | Method for generating an immunogenic T cell response protective against a virus |
| US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| US5688657A (en) | 1988-03-31 | 1997-11-18 | International Bio-Immune Systems, Inc. | Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
| AU1570292A (en) | 1991-02-07 | 1992-09-07 | Board Of Trustees Of The University Of Illinois, The | Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
| JPH07101999A (ja) | 1993-10-06 | 1995-04-18 | Hagiwara Yoshihide | 抗癌ヒトモノクローナル抗体に対する抗イデイオタイプ抗体のアミノ酸配列およびそれをコードするｄｎａ塩基配列 |
| US5643786A (en) | 1995-01-27 | 1997-07-01 | The United States Of America As Represented By The Department Of Health And Human Services | Method for isolating dendritic cells |
| DE19817946A1 (de) | 1998-04-17 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Uterus-Normalgewebe |
| AU3395900A (en) | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
| GB2373500B (en) | 2000-02-04 | 2004-12-15 | Aeomica Inc | Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence |
| DE60109922D1 (de) | 2000-05-31 | 2005-05-12 | Genzyme Corp | Therapeutische verbindungen gegen eierstockkrebs |
-
2001
- 2001-05-30 DE DE60109922T patent/DE60109922D1/de not_active Expired - Lifetime
- 2001-05-30 US US09/870,089 patent/US6737062B2/en not_active Expired - Lifetime
- 2001-05-30 CA CA002410895A patent/CA2410895A1/en not_active Abandoned
- 2001-05-30 AU AU2001265188A patent/AU2001265188A1/en not_active Abandoned
- 2001-05-30 EP EP01939696A patent/EP1284997B1/en not_active Expired - Lifetime
- 2001-05-30 JP JP2002500917A patent/JP2004503217A/ja active Pending
- 2001-05-30 AT AT01939696T patent/ATE292640T1/de not_active IP Right Cessation
- 2001-05-30 WO PCT/US2001/017454 patent/WO2001092306A2/en not_active Ceased
-
2004
- 2004-03-31 US US10/813,859 patent/US20050048068A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006511196A5 (enExample) | ||
| EP2481422A3 (en) | Multiplex vaccines | |
| JP2006514920A5 (enExample) | ||
| JP2006020648A5 (enExample) | ||
| JP2004503217A5 (enExample) | ||
| EP2361930A3 (en) | Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases | |
| ATE494910T1 (de) | Zusammensetzung verpackte virusartige teilchen umfassend zur verstärkung einer immunantwort | |
| JP2007538044A5 (enExample) | ||
| JP2013502918A5 (enExample) | ||
| HUP0004327A3 (en) | Fusion proteins containing human papilloma virus (hpv) proteins and immunological fusion partner with t-helper epitopes to the hpv antigen, as well as vaccine formulations for treatment and/or profilaxis of hpv induced lesions | |
| EP2168596A3 (en) | Immunisation against chlamydia trachomatis | |
| JP2002543769A5 (enExample) | ||
| JP2007504237A5 (enExample) | ||
| JP2003519099A5 (enExample) | ||
| JP2005504513A5 (enExample) | ||
| JP2009515831A5 (enExample) | ||
| JP2007515393A5 (enExample) | ||
| BR0314373A (pt) | Produto imunogênico estável para a indução de anticorpos contra uma ou várias proteìnas antigênicas em um indivìduo, composições farmacêutica, imunogênica e de vacina e processo de preparação de um produto imunogênico | |
| BR0010711A (pt) | Uso de moléculas co-estimulatórias solúveis para intensificar respostas imunes | |
| DK1267924T3 (da) | Immunterapeutiske metoder og sammensætninger | |
| AU2002354806A1 (en) | Parathyroid hormone antibodies and related methods | |
| WO2003089584A3 (en) | Use of parapox b2l protein to modify immune responses to administered antigens | |
| JP2003519668A5 (enExample) | ||
| Files et al. | Self-adjuvanting nanovaccines boost lung-resident CD4+ T cell immune responses in BCG-primed mice | |
| DE60234015D1 (de) | Latentes tuberkulose-diagnostisches antigen und verwendungsmethode |